Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practiceJ. Nucl. Med. 2022 Apr 21;[EPub Ahead of Print], CS Denis, F Cousin, B De Laere, R Hustinx, BR Sautois, N Withofs
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.